Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc

Bullboard Posts

Post by wakondaon Jun 09, 2012 2:49pm

391 Views

Post# 19996269

Money and run....where?

Ummm the last I looked the share price was 0.035. There's no money to take anywhere. Most investors are deep in the whole here. Management knows we're stuck and they seem to be taking full advantage of the situation to set themselves up quite nicely. If you are very brave you would buy more at this price. If not you keep your head down,curse under your breath,and hope for a good result at Flami. Selling now is not an option.

Bullboard Posts

Investing with insurance and protection